期刊
JOURNAL OF PSYCHIATRIC RESEARCH
卷 140, 期 -, 页码 110-116出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2021.05.071
关键词
Inflammation; Cognitive functions; Depression; Chemokines
类别
资金
- Italian Ministry of Health [RF-2011-02350980]
- H2020-EU.3.1.1 grant [754740]
- Fondazione Centro San Raffaele
The study found that elevated levels of chemokines are associated with poor cognitive performance in patients with bipolar disorder, suggesting that an inflammatory state may contribute to neurocognitive deficits.
Background: Cognitive impairment is a core feature of bipolar disorder, with a prevalence of about 64.4% during episodes and 57.1% in euthymia. Recent evidences suggest that cognitive deficits in BD may follow immune dysfunction and elevated levels of inflammatory cytokines have been reported during periods of depression, mania and euthymia, suggesting the presence of a chronic, low-grade inflammatory state. The aim of the study is to investigate if immune/inflammatory markers and especially chemokines associate to cognitive performances. Methods: Seventy-six consecutively admitted inpatients with a depressive episode in course of bipolar disorder performed a neuropsychological evaluation with the Brief Assessment of Cognition in Schizophrenia and plasma blood levels of cytokines, chemokines and growth factors were analyzed with Luminex technology. Results: Higher levels of IL-1 beta, IL-6, CCL2, CCL4, CCL5, CXCL10, and bFGF are associated with the likelihood of having a poor cognitive performance. Limitations: Limitation include the lack of a group of healthy controls and the lack of information regarding previous psychopharmacological treatments, alcohol and tobacco use. Conclusions: Our results confirm the importance of chemokines in bipolar disorder and suggest that inflammatory markers suggestive of a low-grade inflammatory state could contribute to the neurocognitive deficits observed in depressed patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据